8-K ·Filed Oct 6, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
Routine investor materials update with no new quantitative data. Monitor for future clinical trial results or financing announcements as the primary catalysts for this clinical-stage biotech.
Latest settled — T+5d
MAIA ▼ -2.52% at T+5d
NEUTRAL call -2.52% · α vs SPY -2.38% · entry $1.19 → $1.16
Latest observation: T+13 +7.28% FF3 residual α
T+1d
-0.84%
call -0.84% · α -0.60%
$1.18
settled 20d ago
T+5d
-2.52%
call -2.52% · α -2.38%
$1.16
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
MAIA Biotechnology filed an 8-K furnishing a corporate presentation and summary under Regulation FD, posted to its website on October 6, 2026. The filing is a routine disclosure of investor materials with no new material financial data or guidance.
Key Facts
- Filed 8-K on October 6, 2026 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits)
- Company posted a corporate presentation (Exhibit 99.1) and a summary (Exhibit 99.2) to its website on October 6, 2026
- Materials contain forward-looking statements and are furnished, not filed, for SEC purposes
- No financial results, guidance, or material agreements disclosed in the 8-K body
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- Forward-looking statements in the presentation may create unrealistic expectations
- No new clinical or financial data to assess pipeline progress
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-045865 |
| Document: 0001493152-26-045865-index-headers.html | 0001493152-26-045865 |
| Document: 0001493152-26-045865-index.html | 0001493152-26-045865 |
| Document: 0001493152-26-045865.txt | 0001493152-26-045865 |
17 reports for MAIA
83% Hit rate @ T+60 Went positive at some point 10 of 11 best @ T+60▲ +16.94%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | EFFECT | $1.18 | awaiting T+60 | — | $1.18 (+0.00%) |
Oct 6, 2026 21d ago | 8-K | $1.19 | awaiting T+60 | — | $1.18 (−0.84%) |
Sep 25, 2026 4w ago | S-3 | $1.18 | awaiting T+60 | — | $1.18 (+0.00%) |
Sep 16, 2026 5w ago | Press Release | $1.40 | awaiting T+60 | — | $1.18 (−15.71%) |
Sep 15, 2026 6w ago | Press Release | $1.34 | awaiting T+60 | — | $1.18 (−11.94%) |
Sep 15, 2026 6w ago | Insider Cluster | $1.34 | awaiting T+60 | — | $1.18 (−11.94%) |
Jun 3, 2026 20w ago | Press Release | $1.43 $1.38 | ▼ −3.50% | ▼ −6.00% | $1.18 (−17.48%) |
Jun 2, 2026 21w ago | Insider Cluster | $1.35 $1.39 | ▲ +2.96% | ▲ +1.85% | $1.18 (−12.59%) |
May 19, 2026 23w ago | DEFA14A | $1.23 $1.34 | ▲ +8.94% | ▲ +2.65% | $1.18 (−4.07%) |
May 14, 2026 23w ago | 8-K | $1.26 $1.38 | ▲ +9.52% | ▲ +5.01% | $1.18 (−6.35%) |
Showing 10 of 17
US Market Status
Market Closed — Opens Wed (17h 27m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers